Bacteriophage lysins as antibacterials

Critical Care

Volumn 21, Issue 1, 2017, Pages

  Sharma, Umender ^a   Paul, Vivek D ^a  

^a GangaGen Biotechnologies Pvt Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ART 175 LYSIN; BACTERIAL PROTEIN; CF 301 LYSIN; ECTOLYSIN; ENDOLYSIN; LYSIN; N REPHASIN; P128 LYSIN; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; ESCHERICHIA COLI; LETTER; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTERIOPHAGES;

EID: 85018264947     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-017-1681-6     Document Type: Letter

References (9)

1. Opal SM. Non-antibiotic treatments for bacterial diseases in an era of progressive antibiotic resistance. Crit Care. 2016;20:397.
2. Schuch R, Lee HM, Schneider BC, Sauve KL, Law C, Khan BK, Rotolo JA, Horiuchi Y, Couto DE, Raz A, Fischetti VA, Huang DB, Nowinski RC, Wittekind M. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia. J Infect Dis. 2014;209:1469-78.
3. Nair S, Desai S, Poonacha N, Vipra A, Sharma U. Antibiofilm activity and synergistic inhibition of S. aureus biofilms by bactericidal protein P128 in combination with antibiotics. Antimicrob Agents Chemother. 2016;60:7280-9.
4. Briers Y, Walmagh M, Grymonprez B, Biebl M, Pirnay JP, Defraine V, Michiels J, Cenens W, Aertsen A, Miller S, Lavigne R. Art-175 is a highly efficient antibacterial against multidrug-resistant strains and persisters of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2014;58:3774-84.
5. Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, Fischetti VA, Foster S, Gilmore BF, Hancock RE, Harper D, Henderson IR, Hilpert K, Jones BV, Kadioglu A, Knowles D, Ólafsdóttir S, Payne D, Projan S, Shaunak S, Silverman J, Thomas CM, Trust TJ, Warn P, Rex JH. Alternatives to antibiotics-a pipeline portfolio review. Lancet Infect Dis. 2016;16:239-51.
6. Zhang L, Li D, Li X, Hu L, Cheng M, Xia F, Gong P, Wang B, Ge J, Zhang H, Cai R, Wang Y, Sun C, Feng X, Lei L, Han W, Gu J. LysGH15 kills Staphylococcus aureus without being affected by the humoral immune response or inducing inflammation. Sci Rep. 2016;6:29344.
7. Schmelcher M, Loessner MJ. Bacteriophage endolysins: applications for food safety. Curr Opin Biotechnol. 2016;37:76-87.
8. Fischetti VA. Bacteriophage endolysins: A novel anti-infective to control Gram-positive pathogens. Int J Med Microbiol. 2010;300(6):357-62.
9. Schmelcher M, Donovan DM, Loessner MJ. Bacteriophage endolysins as novel antimicrobials. Future Microbiol. 2012;7(10):1147-71.